Kliniske forsøg med Diffust storcellet B-celle lymfom, genmutation
I alt 0 resultater
Intet fundet
Denne side blev automatisk oversat, og nøjagtigheden af oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.
Sponsorer og samarbejdspartnere
- Michael J. Wesley, PhD
- Edanz Group Japan Ltd
- Center for Rare Neurological Diseases, Norcross, GA
- Laboratorios Viñas, S.A.
- Frankel, Amylynne, M.D.
- King Baudouin Foundation
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- Gulsah Ilhan
- Walgreens Co.
- Ana Paula Costella
- Korrus Inc.
- Manmohan Cardiothoracic Vascular and Transplant Center
- Ruba Musharbash Nutrition Consultancy Center
- IRCCS Don Gnocchi, Milano, Italy
- HeartPoint Global
- Army Hospital, Percy
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- Pharmaspecific
- Fundación Pública Andaluza Progreso y Salud
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- Se den fulde liste
Medicinske tilstande
- Alvorlig atopisk dermatitis
- Lammelse af stemmebånd eller strubehoved
- Svækkelse, Koordinering
- Arteriovenøs misdannelse i hjernen
- Pelvis Tumors
- Ukontrolleret type 2-diabetes mellitus
- Ankyloserede tænder
- Udviklingssprogsforstyrrelse og sprogsvækkelse
- Kardiovaskulære resultater
- Gastroenteritis Rotavirus
- Ondartet intrakraniel kimcelletumor
- Patienter, der gennemgår koronararterie bypasstransplantat (CABG) operation, der kræver ekstrakorporal cirkulation
- Lunge neuroendokrin tumor
- Nyreskade
- Ansigtsinddragelse
- Koagulationsforstyrrelse Neonatal
- Overgangsalderen
- Lokaliseret ikke-operabel primær leverkræft hos voksne
- Kognitiv funktion, social 1
- Ann Arbor Stage IVB Hodgkin lymfom
- Se den fulde liste
Narkotikainterventioner
- Lidokain/ketamin
- Transdermal østradiol
- Tocilizumab 20 MG/ML intravenøs opløsning [ACTEMRA]
- Interleukin-2
- Rituximab plus CHOP
- 5-Fluorouracil
- Insulin
- Thiotepa
- Guanfacin med forlænget frigivelse
- Camrelizumab til injektion (200 mg, iv), D1, Q2W, 14-dages cyklus
- CD25 behandling
- Interferon beta-1b (Betaferon, BAY86-5046)
- LDEPA
- Apremilast
- Methotrexate
- Ozanimod
- Exendin 9-39
- FHND5071
- Dexmedetomidin
- Miglustat
- Se den fulde liste
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Estonia
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Jordan
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Poland
- Contract Research Organizations in United Kingdom
- Contract Research Organizations in Zimbabwe
- CRO list by country